DI
David Irwin
Hematology & Oncology
Credentials: · ·
History
- 1987–1990
Hematology and Medical Oncology
- 1984–1987
Internal Medicine
- 1980–1984
Research
A phase 2 study of bortezomib in relapsed, refractory myeloma
New England Journal of Medicine · 2003 · 2,206 citations
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
New England Journal of Medicine · 2005 · 2,069 citations
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
British Journal of Haematology · 2004 · 598 citations
18 papers
18 papers
13 papers
- JB
9 papers
9 papers
- BB
8 papers
- DS
8 papers
7 papers
